MannKind Corp. (MNKD)
3.80
-0.15
(-3.80%)
USD |
NASDAQ |
Oct 02, 16:00
3.80
0.00 (0.00%)
After-Hours: 20:00
MannKind Debt to Equity Ratio : -6.494 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.494 |
| March 31, 2026 | -7.377 |
| December 31, 2025 | -9.278 |
| September 30, 2025 | -5.072 |
| June 30, 2025 | -2.781 |
| March 31, 2025 | -2.628 |
| December 31, 2024 | -1.995 |
| September 30, 2024 | -1.655 |
| June 30, 2024 | -1.498 |
| March 31, 2024 | -1.627 |
| December 31, 2023 | -1.553 |
| September 30, 2023 | -1.524 |
| June 30, 2023 | -1.481 |
| March 31, 2023 | -1.506 |
| December 31, 2022 | -1.550 |
| September 30, 2022 | -1.614 |
| June 30, 2022 | -1.556 |
| March 31, 2022 | -1.665 |
| December 31, 2021 | -1.857 |
| September 30, 2021 | -1.556 |
| June 30, 2021 | -1.589 |
| March 31, 2021 | -1.951 |
| December 31, 2020 | -0.7244 |
| September 30, 2020 | -0.7038 |
| June 30, 2020 | -0.7281 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.6485 |
| December 31, 2019 | -0.6754 |
| September 30, 2019 | -0.6972 |
| June 30, 2019 | -0.571 |
| March 31, 2019 | -0.6114 |
| December 31, 2018 | -0.6359 |
| September 30, 2018 | -0.5565 |
| June 30, 2018 | -0.6689 |
| March 31, 2018 | -0.668 |
| December 31, 2017 | -0.7715 |
| September 30, 2017 | -0.6936 |
| June 30, 2017 | -0.7849 |
| March 31, 2017 | -0.7941 |
| December 31, 2016 | -0.857 |
| September 30, 2016 | -0.9558 |
| June 30, 2016 | -0.6072 |
| March 31, 2016 | -0.5917 |
| December 31, 2015 | -0.6111 |
| September 30, 2015 | -1.565 |
| June 30, 2015 | -2.178 |
| March 31, 2015 | -2.293 |
| December 31, 2014 | -3.008 |
| September 30, 2014 | -5.440 |
| June 30, 2014 | -4.014 |
| March 31, 2014 | 9.926 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| United Therapeutics Corp. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Gilead Sciences, Inc. | 2.219 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| Ocugen, Inc. | -5.314 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 732.30M |
| Total Liabilities (Quarterly) | 799.50M |
| Shareholders Equity (Quarterly) | -67.20M |
| Current Ratio | 1.720 |
| Net Debt Paydown Yield | -4.28% |